• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Polycystic ovarian syndrome is associated with an increased risk of pancreatic cancer

byKassandra McFarlaneandSze Wah Samuel Chan
October 17, 2022
in Chronic Disease, Endocrinology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Polycystic ovarian syndrome (PCOS) diagnosis puts women at 1.9 times higher risk of pancreatic cancer

2. PCOS was an independent risk factor for the development of pancreatic cancer even after adjusting for type 2 diabetes.

Evidence Rating Level: 3 (Average)

Study Rundown: Polycystic ovarian syndrome (PCOS) is positively associated with the development of a variety of carcinogenic processes. Few studies have found an association between PCOS and pancreatic cancer. Risk prediction for pancreatic cancer remains poor and often presents with advanced disease. This study further explored the relationship between PCOS and the risk for pancreatic adenocarcinoma development using data from the Memorial Sloan Kettering Cancer Center Pancreatic Tumor Registry. Data obtained were used to determine associations between PCOS and pancreatic cancer and found that there was a positive association. Adjusting for type 2 diabetes did not significantly alter the results. Limitations to this study include the small sample size and case-control study design. Overall, the results from this study suggest that

Click to read the study in JAMA Oncology

Relevant Reading: Association between polycystic ovary syndrome and cancer risk

RELATED REPORTS

Artificial Intelligence and Real World Data Speed Up Drug Development

#VisualAbstract: Cabozantinib Improved Progression-Free Survival in Advanced Neuroendocrine 2m -m Tumors

Bariatric surgery may improve rates for spontaneous ovulation in patients with polycystic ovarian syndrome and obesity

In-Depth [case-control study]: This case-control study included data from 655 female patients who were 21 years or older. There were 446 patients in the ‘cases’ group, who had pancreatic adenocarcinoma, and 209 ‘control’ subjects who did not have cancer. Exclusion criteria included a family history of pancreatic cancer, a diagnosis of pancreatitis, or a diagnosis of pancreatic cancer that was diagnosed less than 5 years after their PCOS diagnosis. PCOS was found to be positively associated with a risk of pancreatic cancer (odds ratio (OR), 1.88; 95% confidence interval (CI), 1.02-3.46). When adjusting for type 2 diabetes, there was a weaker association (OR, 1.78; 95% CI, 0.95-3.34). Estimates were not substantially altered by applying exclusion criteria.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pancreatic cancerpcos
Previous Post

Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

Next Post

Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

RelatedReports

AI Roundup

Artificial Intelligence and Real World Data Speed Up Drug Development

May 27, 2025
#VisualAbstract: Perioperative Durvalumab with Neoadju-vant Chemotherapy Improved Survival in Operable Bladder Cancer
StudyGraphics

#VisualAbstract: Cabozantinib Improved Progression-Free Survival in Advanced Neuroendocrine 2m -m Tumors

October 1, 2024
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Bariatric surgery may improve rates for spontaneous ovulation in patients with polycystic ovarian syndrome and obesity

June 12, 2024
Pediatrics

Childhood adiposity associated with adolescent polycystic ovary syndrome

May 10, 2024
Next Post
Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT

Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

Prevalence of hypertension among adolescents varies by race and BMI

Beneficial effect of intensive blood pressure control on cardiovascular and all-cause mortality not persist after trial intervention – a secondary analysis of the SPRINT trial

Shorter time to angioplasty may improve heart attack outcomes

Percutaneous coronary intervention inefficacious in improving severe ischemic left ventricular dysfunction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • Large language models show potential to provide feedback on research papers on a large-scale
  • #VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.